Biblio

Filters: Author is Sala, Luca [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

C

Giacomelli E, Sala L, van Oostwaard DWard-, Bellin M. Cardiac microtissues from human pluripotent stem cells recapitulate the phenotype of long-QT syndrome. Biochem Biophys Res Commun. 2021;572:118-124.

F

Schwartz PJ, Gnecchi M, Dagradi F, Castelletti S, Parati G, Spazzolini C, Sala L, Crotti L. From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2. Eur Heart J. 2019.

G

Lavra L, Magi F, Ulivieri A, Morgante A, Paulis M, Sala L, Pedrazzini M, Polisca P, Rocchetti M, Calò L, et al. Generation and characterization of the human induced pluripotent stem cell (hiPSC) line NCUFi001-A from a patient carrying KCNQ1 G314S mutation. Stem Cell Res. 2021;54:102418.

H

Giacomelli E, Meraviglia V, Campostrini G, Cochrane A, Cao X, van Helden RWJ, Garcia AKrotenberg, Mircea M, Kostidis S, Davis RP, et al. Human-iPSC-Derived Cardiac Stromal Cells Enhance Maturation in 3D Cardiac Microtissues and Reveal Non-cardiomyocyte Contributions to Heart Disease. Cell Stem Cell. 2020.

I

Brandão KO, van den Brink L, Miller DC, Grandela C, van Meer BJ, Mol MPH, de Korte T, Tertoolen LGJ, Mummery CL, Sala L, et al. Isogenic Sets of hiPSC-CMs Harboring Distinct KCNH2 Mutations Differ Functionally and in Susceptibility to Drug-Induced Arrhythmias. Stem Cell Reports. 2020;15(5):1127-1139.

Q

van Meer BJ, Sala L, Tertoolen LGJ, Smith GL, Burton FL, Mummery CL. Quantification of Muscle Contraction In Vitro and In Vivo Using MUSCLEMOTION Software: From Stem Cell-Derived Cardiomyocytes to Zebrafish and Human Hearts. Curr Protoc Hum Genet. 2018:e67.